NO20006456D0 - En mutant human hepatitt B viral stamme og anvendelser derav - Google Patents

En mutant human hepatitt B viral stamme og anvendelser derav

Info

Publication number
NO20006456D0
NO20006456D0 NO20006456A NO20006456A NO20006456D0 NO 20006456 D0 NO20006456 D0 NO 20006456D0 NO 20006456 A NO20006456 A NO 20006456A NO 20006456 A NO20006456 A NO 20006456A NO 20006456 D0 NO20006456 D0 NO 20006456D0
Authority
NO
Norway
Prior art keywords
mutant human
human hepatitis
viral strain
viral
strain
Prior art date
Application number
NO20006456A
Other languages
English (en)
Other versions
NO20006456L (no
Inventor
Chong Jin Oon
Gek Keow Lim
Yi Zhao
Wei Ning Chen
Original Assignee
Government Of The Republic Of Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Government Of The Republic Of Singapore filed Critical Government Of The Republic Of Singapore
Publication of NO20006456D0 publication Critical patent/NO20006456D0/no
Publication of NO20006456L publication Critical patent/NO20006456L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20006456A 1998-06-19 2000-12-18 En mutant human hepatitt B viral stamme og anvendelser derav NO20006456L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SG1998/000046 WO1999066048A1 (en) 1998-06-19 1998-06-19 A mutant human hepatitis b viral strain and uses thereof

Publications (2)

Publication Number Publication Date
NO20006456D0 true NO20006456D0 (no) 2000-12-18
NO20006456L NO20006456L (no) 2001-02-16

Family

ID=20429862

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006456A NO20006456L (no) 1998-06-19 2000-12-18 En mutant human hepatitt B viral stamme og anvendelser derav

Country Status (22)

Country Link
US (1) US6558675B1 (no)
EP (1) EP1098981A1 (no)
JP (1) JP2002518014A (no)
KR (1) KR100498118B1 (no)
CN (1) CN1322251A (no)
AR (1) AR020093A1 (no)
AU (1) AU756866B2 (no)
BG (1) BG105066A (no)
BR (1) BR9815913A (no)
CA (1) CA2330935C (no)
HU (1) HUP0103409A3 (no)
IL (1) IL140364A0 (no)
IS (1) IS5778A (no)
MX (1) MXPA00012720A (no)
MY (1) MY118955A (no)
NO (1) NO20006456L (no)
NZ (1) NZ508890A (no)
PL (1) PL192129B1 (no)
TR (1) TR200003777T2 (no)
UA (1) UA73476C2 (no)
WO (1) WO1999066048A1 (no)
YU (1) YU80600A (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006132598A1 (en) 2005-06-07 2006-12-14 Temasek Life Sciences Laboratory Limited Porcine circovirus type 2 vaccines
EP3708176A1 (en) * 2019-03-15 2020-09-16 Centre National De La Recherche Scientifique -Cnrs- Mutant vsv ectodomain polypeptide and uses thereof
DK4037708T3 (da) 2019-09-30 2024-09-30 Gilead Sciences Inc HBV-vacciner og fremgangsmåder til at behandle HBV
CN113201051B (zh) * 2021-04-27 2022-08-02 复旦大学 一种乙肝病毒表面蛋白突变体及其在抗乙肝病毒中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401987D0 (en) * 1994-02-02 1994-03-30 Imperial College Modified nucleic acid
US5980901A (en) * 1996-09-18 1999-11-09 The Board Of Regents Of The University Of Texas System Viral defective interfering particles and uses thereof

Also Published As

Publication number Publication date
MY118955A (en) 2005-02-28
AU7795198A (en) 2000-01-05
US6558675B1 (en) 2003-05-06
PL345573A1 (en) 2001-12-17
CA2330935A1 (en) 1999-12-23
BG105066A (en) 2001-09-28
JP2002518014A (ja) 2002-06-25
NZ508890A (en) 2004-04-30
IL140364A0 (en) 2002-02-10
HUP0103409A2 (hu) 2001-12-28
YU80600A (sh) 2005-06-10
NO20006456L (no) 2001-02-16
UA73476C2 (en) 2005-08-15
TR200003777T2 (tr) 2001-06-21
AU756866B2 (en) 2003-01-23
CA2330935C (en) 2005-05-10
AR020093A1 (es) 2002-04-10
WO1999066048A1 (en) 1999-12-23
HUP0103409A3 (en) 2003-10-28
MXPA00012720A (es) 2002-05-08
PL192129B1 (pl) 2006-09-29
KR100498118B1 (ko) 2005-07-01
KR20010106129A (ko) 2001-11-29
BR9815913A (pt) 2001-12-26
IS5778A (is) 2000-12-19
CN1322251A (zh) 2001-11-14
EP1098981A1 (en) 2001-05-16

Similar Documents

Publication Publication Date Title
NO983965D0 (no) Polymer-organoleire-kompositter og deres fremstilling
NO964958D0 (no) Aluminium-scandiumlegeringer og deres anvendelse
DK1019358T4 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
BR9607458A (pt) Vacina contra hepatite b
BR9609258A (pt) Vacinas contra hepatite c
NO995811D0 (no) Selvgjenopprettende og selvbekreftende kryptosystemer
NO20006457D0 (no) Vaksine-indusert hepatitt B viral stamme og anvendelser derav
DK1068238T3 (da) Integrinheterodimer og subunit deraf
PT955810E (pt) Misturas solidas a base de sulfonilureias e adjuvantes
DE69822097T2 (de) Dehnungsaufnehmer und dessen Verwendung
DK0690065T3 (da) Biphenyl-2,2'-diyl-bis-diphenylphosphiner, deres fremstilling og deres anvendelse
EP0711310A4 (en) Human antibodies against varicella-zoster virus
NO20005502D0 (no) Polymerer og deres anvendelse
NO20006456D0 (no) En mutant human hepatitt B viral stamme og anvendelser derav
DK1073462T3 (da) Kombinationsvaccine mod hepatitis A og hepatitis B
BR9407988A (pt) Desenho e produçao de vacina
HK1037385A (en) A mutant human hepatitis b viral strain and uses thereof
HK1037211A (en) A vaccine-induced hepatitis b viral strain and uses thereof
SI1073462T1 (sl) Kombinirano cepivo proti hepatitisu A in hepatitisu B
DE69805935D1 (de) Insektizide und akarizide 1,4-Diaryl-2,3-difluor-2-butene
FR2768956B1 (fr) Machoire a touches reglables et etau en faisant application
NO20011749D0 (no) Generering og opprettholdelse av dokumentdatabaser
NO981089D0 (no) Epoksy-azetidinoner, fremstilling og anvendelse derav
KR960026762U (ko) 스윙연습 및 체력단련 보조기구
KR970051007U (ko) 편리성과 기능성을 추가한 훌라후프

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application